Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(5):347-357; doi:10.1093/jnci/93.5.347
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Senchenkov, A.
Right arrow Articles by Cabot, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Senchenkov, A.
Right arrow Articles by Cabot, M. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 5, 347-357, March 7, 2001
© 2001 Oxford University Press

REVIEW

Targeting Ceramide Metabolism—a Strategy for Overcoming Drug Resistance

Alex Senchenkov, David A. Litvak, Myles C. Cabot

Affiliation of authors: Breast Cancer Research Program and Chemotherapeutics, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA.

Correspondence to: Myles C. Cabot, Ph.D., Breast Cancer Research Program and Chemotherapeutics, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Blvd., Santa Monica, CA 90404 (e-mail: cabot{at}jwci.org).

Inherent or acquired drug resistance, which frequently characterizes cancer cells, is caused by multiple mechanisms, including dysfunctional metabolism of the lipid second messenger ceramide. Ceramide, the basic structural unit of the sphingolipids, plays a role in activating cell death signals initiated by cytokines, chemotherapeutic agents, and ionizing radiation. Recent discoveries about the metabolism of ceramide suggest that this agent may have an important influence on the effectiveness of various cancer therapeutics. In particular, the cytotoxic effect of chemotherapy is decreased when generation of ceramide is impaired but is increased when the degradation of ceramide is blocked. Herein, we review the mechanisms of resistance to chemotherapeutic agents in terms of ceramide metabolism.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
H. Wang, B. J. Maurer, Y.-Y. Liu, E. Wang, J. C. Allegood, S. Kelly, H. Symolon, Y. Liu, A. H. Merrill, Jr., V. Gouaze-Andersson, et al.
N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
Mol. Cancer Ther., September 1, 2008; 7(9): 2967 - 2976.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y.-Y. Liu, J. Y. Yu, D. Yin, G. A. Patwardhan, V. Gupta, Y. Hirabayashi, W. M. Holleran, A. E. Giuliano, S. M. Jazwinski, V. Gouaze-Andersson, et al.
A role for ceramide in driving cancer cell resistance to doxorubicin
FASEB J, July 1, 2008; 22(7): 2541 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
I. A. Savtchouk, F. J. Mattie, and A. A. Ollis
Ceramide: From Embryos to Tumors
Sci. Signal., July 10, 2007; 2007(394): jc1 - jc1.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. E. van Vlerken, Z. Duan, M. V. Seiden, and M. M. Amiji
Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer
Cancer Res., May 15, 2007; 67(10): 4843 - 4850.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Cowart and Y. A. Hannun
Selective Substrate Supply in the Regulation of Yeast de Novo Sphingolipid Synthesis
J. Biol. Chem., April 20, 2007; 282(16): 12330 - 12340.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. M. Berchtold, Z.-H. Wu, T. T. Huang, and S. Miyamoto
Calcium-Dependent Regulation of NEMO Nuclear Export in Response to Genotoxic Stimuli
Mol. Cell. Biol., January 15, 2007; 27(2): 497 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. H. Ahn, C.-C. Chang, and J. J. Schroeder
Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
Experimental Biology and Medicine, November 1, 2006; 231(10): 1664 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Pchejetski, M. Golzio, E. Bonhoure, C. Calvet, N. Doumerc, V. Garcia, C. Mazerolles, P. Rischmann, J. Teissie, B. Malavaud, et al.
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
Cancer Res., December 15, 2005; 65(24): 11667 - 11675.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Z. Wu, R. Tandon, J. Ziembicki, J. Nagano, K. M. Hujer, R. T. Miller, and C. Huang
Role of ceramide in Ca2+-sensing receptor-induced apoptosis
J. Lipid Res., July 1, 2005; 46(7): 1396 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. E. Modrak, T. M. Cardillo, G. A. Newsome, D. M. Goldenberg, and D. V. Gold
Synergistic Interaction between Sphingomyelin and Gemcitabine Potentiates Ceramide-Mediated Apoptosis in Pancreatic Cancer
Cancer Res., November 15, 2004; 64(22): 8405 - 8410.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Norris-Cervetto, R. Callaghan, F. M. Platt, R. A. Dwek, and T. D. Butters
Inhibition of Glucosylceramide Synthase Does Not Reverse Drug Resistance in Cancer Cells
J. Biol. Chem., September 24, 2004; 279(39): 40412 - 40418.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Batra, C. P. Reynolds, and B. J. Maurer
Fenretinide Cytotoxicity for Ewing's Sarcoma and Primitive Neuroectodermal Tumor Cell Lines Is Decreased by Hypoxia and Synergistically Enhanced by Ceramide Modulators
Cancer Res., August 1, 2004; 64(15): 5415 - 5424.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Daido, T. Kanzawa, A. Yamamoto, H. Takeuchi, Y. Kondo, and S. Kondo
Pivotal Role of the Cell Death Factor BNIP3 in Ceramide-Induced Autophagic Cell Death in Malignant Glioma Cells
Cancer Res., June 15, 2004; 64(12): 4286 - 4293.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y.-Y. Liu, T. Y. Han, J. Y. Yu, A. Bitterman, A. Le, A. E. Giuliano, and M. C. Cabot
Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells
J. Lipid Res., May 1, 2004; 45(5): 933 - 940.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. P. Struckhoff, R. Bittman, M. E. Burow, S. Clejan, S. Elliott, T. Hammond, Y. Tang, and B. S. Beckman
Novel Ceramide Analogs as Potential Chemotherapeutic Agents in Breast Cancer
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 523 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
V. Gouaze, J. Y. Yu, R. J. Bleicher, T.-Y. Han, Y.-Y. Liu, H. Wang, M. M. Gottesman, A. Bitterman, A. E. Giuliano, and M. C. Cabot
Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy
Mol. Cancer Ther., May 1, 2004; 3(5): 633 - 640.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Grazide, A.-D. Terrisse, S. Lerouge, G. Laurent, and J.-P. Jaffrezou
Cytoprotective Effect of Glucosylceramide Synthase Inhibition against Daunorubicin-induced Apoptosis in Human Leukemic Cell Lines
J. Biol. Chem., April 30, 2004; 279(18): 18256 - 18261.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
F.-L. Chi, Y.-S. Yuan, S.-Y. Wang, and Z.-M. Wang
Study on Ceramide Expression and DNA Content in Patients With Healthy Mucosa, Leukoplakia, and Carcinoma of the Larynx
Arch Otolaryngol Head Neck Surg, March 1, 2004; 130(3): 307 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
R. Simstein, M. Burow, A. Parker, C. Weldon, and B. Beckman
Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System
Experimental Biology and Medicine, October 1, 2003; 228(9): 995 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius
Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo
Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Ravid, A. Tsaba, P. Gee, R. Rasooly, E. A. Medina, and T. Goldkorn
Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1082 - L1092.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Prinetti, L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al.
Altered Sphingolipid Metabolism in N-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells
J. Biol. Chem., February 14, 2003; 278(8): 5574 - 5583.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. A. Hannun and L. M. Obeid
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
J. Biol. Chem., July 12, 2002; 277(29): 25847 - 25850.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Wang, A. E. Giuliano, and M. C. Cabot
Enhanced de Novo Ceramide Generation through Activation of Serine Palmitoyltransferase by the P-Glycoprotein Antagonist SDZ PSC 833 in Breast Cancer Cells
Mol. Cancer Ther., July 1, 2002; 1(9): 719 - 726.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Gao, S. Fan, I. D. Goldberg, J. Laterra, R. N. Kitsis, and E. M. Rosen
Hepatocyte Growth Factor/Scatter Factor Blocks the Mitochondrial Pathway of Apoptosis Signaling in Breast Cancer Cells
J. Biol. Chem., December 7, 2001; 276(50): 47257 - 47265.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Senchenkov, T.-Y. Han, H. Wang, A. E. Frankel, T. J. Kottke, S. H. Kaufmann, and M. C. Cabot
Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF
Blood, September 15, 2001; 98(6): 1927 - 1934.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Wang, B. J. Maurer, C. P. Reynolds, and M. C. Cabot
N-(4-Hydroxyphenyl)retinamide Elevates Ceramide in Neuroblastoma Cell Lines by Coordinate Activation of Serine Palmitoyltransferase and Ceramide Synthase
Cancer Res., July 1, 2001; 61(13): 5102 - 5105.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.